Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;26(35):2100826.
doi: 10.2807/1560-7917.ES.2021.26.35.2100826.

Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19 vaccines against asymptomatic SARS-CoV-2 infection

Affiliations
Comment

Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19 vaccines against asymptomatic SARS-CoV-2 infection

Ying-Wen Chen et al. Euro Surveill. 2021 Sep.
No abstract available

Keywords: COVID-19 vaccines; asymptomatic SARS-CoV-2 infection; vaccine effectiveness; vaccine efficacy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment in

Comment on

References

    1. Harder T, Koch J, Vygen-Bonnet S, Külper-Schiek W, Pilic A, Reda S, et al. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surveill. 2021;26(28):2100563. 10.2807/1560-7917.ES.2021.26.28.2100563 - DOI - PMC - PubMed
    1. Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021;397(10282):1351-62. 10.1016/S0140-6736(21)00628-0 - DOI - PMC - PubMed
    1. Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412-23. 10.1056/NEJMoa2101765 - DOI - PMC - PubMed
    1. Vaccines and Related Biological Products Advisory Committee, U.S.Food and Drug Administration (FDA). mRNA–1273. Sponsor briefing document addendum. Silver Spring: FDA; 17 Dec 2020. Available from: https://www.fda.gov/media/144453/download